Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 2-design, manufacturing, and testing of the ultraviolet and visible channel.

Applied optics

Patel MR, Antoine P, Mason J, Leese M, Hathi B, Stevens AH, Dawson D, Gow J, Ringrose T, Holmes J, Lewis SR, Beghuin D, van Donink P, Ligot R, Dewandel JL, Hu D, Bates D, Cole R, Drummond R, Thomas IR, Depiesse C, Neefs E, Equeter E, Ristic B, Berkenbosch S, Bolsée D, Willame Y, Vandaele AC, Lesschaeve S, De Vos L, Van Vooren N, Thibert T, Mazy E, Rodriguez-Gomez J, Morales R, Candini GP, Pastor-Morales MC, Sanz R, Aparicio Del Moral B, Jeronimo-Zafra JM, Gómez-López JM, Alonso-Rodrigo G, Pérez-Grande I, Cubas J, Gomez-Sanjuan AM, Navarro-Medina F, BenMoussa A, Giordanengo B, Gissot S, Bellucci G, Lopez-Moreno JJ.
PMID: 28375240
Appl Opt. 2017 Apr 01;56(10):2771-2782. doi: 10.1364/AO.56.002771.

NOMAD is a spectrometer suite on board the ESA/Roscosmos ExoMars Trace Gas Orbiter, which launched in March 2016. NOMAD consists of two infrared channels and one ultraviolet and visible channel, allowing the instrument to perform observations quasi-constantly, by taking...

[Professor Bernhard Milt, 1896-1956].

Centaurus; international magazine of the history of science and medicine

FUETER E.
PMID: 13383564
Centaurus. 1956;4(4):378-81.

No abstract available.

NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 1--design, manufacturing and testing of the infrared channels.

Applied optics

Neefs E, Vandaele AC, Drummond R, Thomas IR, Berkenbosch S, Clairquin R, Delanoye S, Ristic B, Maes J, Bonnewijn S, Pieck G, Equeter E, Depiesse C, Daerden F, Van Ransbeeck E, Nevejans D, Rodriguez-Gómez J, López-Moreno JJ, Sanz R, Morales R, Candini GP, Pastor-Morales MC, Aparicio del Moral B, Jeronimo-Zafra JM, Gómez-López JM, Alonso-Rodrigo G, Pérez-Grande I, Cubas J, Gomez-Sanjuan AM, Navarro-Medina F, Thibert T, Patel MR, Bellucci G, De Vos L, Lesschaeve S, Van Vooren N, Moelans W, Aballea L, Glorieux S, Baeke A, Kendall D, De Neef J, Soenen A, Puech PY, Ward J, Jamoye JF, Diez D, Vicario-Arroyo A, Jankowski M.
PMID: 26479628
Appl Opt. 2015 Oct 01;54(28):8494-520. doi: 10.1364/AO.54.008494.

NOMAD is a spectrometer suite on board ESA's ExoMars trace gas orbiter due for launch in January 2016. NOMAD consists of two infrared channels and one ultraviolet and visible channel allowing the instrument to perform observations quasi-constantly, by taking...

Bridging the gap between basic science and clinical practice: the role of organizations in addressing clinician barriers.

Implementation science : IS

Beckett M, Quiter E, Ryan G, Berrebi C, Taylor S, Cho M, Pincus H, Kahn K.
PMID: 21463517
Implement Sci. 2011 Apr 04;6:35. doi: 10.1186/1748-5908-6-35.

BACKGROUND: New National Institutes of Health policies call for expansion of practice-based research to improve the clinical research enterprise and facilitate dissemination of evidence-based medicine.OBJECTIVE: This paper describes organizational strategies that influence clinicians' decisions to participate in clinical research.DESIGN:...

[The role of science in modern European culture].

Gesnerus

FUETER E.
PMID: 14860451
Gesnerus. 1951;8(1):66-84.

No abstract available.

A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer.

Oncotarget

Keppens C, Tack V, Hart N', Tembuyser L, Ryska A, Pauwels P, Zwaenepoel K, Schuuring E, Cabillic F, Tornillo L, Warth A, Weichert W, Dequeker E.
PMID: 29755669
Oncotarget. 2018 Apr 17;9(29):20524-20538. doi: 10.18632/oncotarget.24980. eCollection 2018 Apr 17.

Biomarker analysis has become routine practice in the treatment of non-small cell lung cancer (NSCLC). To ensure high quality testing, participation to external quality assessment (EQA) schemes is essential. This article provides a longitudinal overview of the EQA performance...

Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group.

Cancers

Van Bockstal MR, Cooks M, Nederlof I, Brinkhuis M, Dutman A, Koopmans M, Kooreman L, van der Vegt B, Verhoog L, Vreuls C, Westenend P, Kok M, van Diest PJ, Nauwelaers I, Laudus N, Denkert C, Rimm D, Siziopikou KP, Ely S, Zardavas D, Roberts M, Floris G, Hartman J, Acs B, Peeters D, Bartlett JMS, Dequeker E, Salgado R, Giudici F, Michiels S, Horlings H, van Deurzen CHM.
PMID: 34638394
Cancers (Basel). 2021 Sep 29;13(19). doi: 10.3390/cancers13194910.

Patients with advanced triple-negative breast cancer (TNBC) benefit from treatment with atezolizumab, provided that the tumor contains ≥1% of PD-L1/SP142-positive immune cells. Numbers of tumor-infiltrating lymphocytes (TILs) vary strongly according to the anatomic localization of TNBC metastases. We investigated...

Showing 1 to 7 of 7 entries